Effect of leukoreduction on transfusion-related immunomodulation in patients undergoing cardiac surgery

Atif Irfan Khan1, Gopal Kumar Patidar1, R Lakshmy2

  • 1Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.

Insights

Leukocyte reduction in blood transfusions for cardiac surgery patients can reduce complications. Leukofiltration proved more effective than buffy coat depletion in mitigating transfusion-related immunomodulation effects.

Area of Science:

  • Transfusion Medicine
  • Cardiac Surgery
  • Immunomodulation

Background:

  • Cardiac surgery patients often require blood transfusions.
  • Transfusion-related immunomodulation (TRIM) is a concern in these patients.
  • Different methods exist to reduce leukocytes in transfused blood products.

Purpose of the Study:

  • To evaluate the impact of varying leukocyte amounts in transfusions on cardiac surgery outcomes.
  • To compare the effectiveness of leukofiltration (LR) versus buffy coat depletion (BCD) and non-leukoreduced (NLR) blood products.

Main Methods:

  • Prospective, single-blinded cohort study of 150 cardiac surgery patients.
  • Patients divided into three groups: LR, BCD, and NLR.
  • Outcomes measured included ICU/hospital stay, mechanical ventilation duration, infection, kidney injury, and cytokine levels (FAS-L, IL-10, INF-γ).

Main Results:

  • The LR group showed a trend towards shorter ICU and hospital stays compared to NLR and BCD groups.
  • Mechanical ventilation duration was significantly shorter in the LR group versus the NLR group.
  • The NLR group had a higher risk of postoperative kidney injury compared to BCD and LR groups; IL-10 levels decreased in the LR group.

Conclusions:

  • Leukocyte depletion reduces TRIM effects in cardiac surgery patients, with effectiveness depending on the reduction method.
  • Leukofiltration is more effective than buffy coat depletion in mitigating these effects.
Abstract

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
196
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
691
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
205